EXEL
NASDAQ · Biotechnology
Exelixis Inc
$58.15
+0.93 (+1.63%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+46.07%
YTD
+33.43%
Open$57.65
Previous Close$57.22
Day High$59.09
Day Low$57.33
52W High$59.72
52W Low$33.76
Volume—
Avg Volume2.01M
Market Cap14.49B
P/E Ratio16.84
EPS$3.18
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$43.59
Above
SMA 200
$41.49
Above
RSI (14)
62
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
27 analysts
Price Target
+99.7% upside
Current
$58.15
$58.15
Target
$116.10
$116.10
$78.53
$116.10 avg
$123.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.04B | 1.81B | 2.68B |
| Net Income | 689.47M | 549.48M | -77,688,294 |
| Profit Margin | 33.7% | 32.0% | -2.9% |
| EBITDA | 794.05M | 667.98M | -84,355,918 |
| Free Cash Flow | — | — | -70,301,392 |
| Rev Growth | +12.9% | +12.9% | +9.9% |
| Debt/Equity | — | — | 0.16 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |